Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer

A major challenge in breast cancer therapy is the lack of an effective therapeutic option for a particularly aggressive subtype of breast cancer, triple-negative breast cancer. Here we provide the first preclinical evidence that a second-generation selenium compound, methylseleninic acid, significan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Qi, Yanfeng, Fu, Xueqi, Xiong, Zhenggang, Zhang, Haitao, Hill, Steven M., Rowan, Brian G., Dong, Yan
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3279411/
https://ncbi.nlm.nih.gov/pubmed/22348099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0031539
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars